New therapeutic target for metabolic syndrome: PPARdelta

Endocr J. 2007 Jun;54(3):347-57. doi: 10.1507/endocrj.kr-99. Epub 2007 Apr 3.

Authors

Sadao Takahashi¹, Toshiya Tanaka, Juro Sakai

Affiliation

¹ Third Department of Internal Medicine, Faculty of Medical Sciences, University of Fukui, Japan.

PMID: 17409576
DOI: 10.1507/endocrj.kr-99

No abstract available

Publication types

Review

MeSH terms

Adipose Tissue / metabolism
Animals
Atherosclerosis / drug therapy
Atherosclerosis / etiology
Carbohydrate Metabolism / genetics
Energy Metabolism / genetics
Energy Metabolism / physiology
Fatty Acids / metabolism
Humans
Lipoproteins / metabolism
Liver / metabolism
Metabolic Syndrome / drug therapy*
Mice
Mice, Knockout
Models, Biological
Muscle, Skeletal / metabolism
Neoplasms / genetics
Oxidation-Reduction
PPAR delta / agonists*
PPAR delta / genetics
PPAR delta / physiology
Polymorphism, Single Nucleotide

Substances

Fatty Acids
Lipoproteins
PPAR delta